Program
iron isomaltoside 1000
Also written as “Iron isomaltoside 1000”, “Iron isomaltoside/ferric derisomaltose” and “Monofer”.
Its studies are mostly in Anemia, Iron-Deficiency · Inflammatory Bowel Diseases · Renal Insufficiency, Chronic · Iron Deficiencies · Postpartum Hemorrhage, led by 2 companies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Pharmacosmos | 292 open or running | phase 4since Jun 13, 2017 | Sep 27, 2007 | Apr 30, 2027phase 3 · NCT05179226 |
| Sichuan Huiyu Pharmaceutical | 11 open or running | phase 1since Jul 27, 2026 | Jul 27, 2026 | none ahead |
Also a collaborator on its studies: Boji Medical Technology, BioStata, ClinStar, Laboratory Corporation of America and ClinSmart.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 12 studies since Sep 27, 2007.
- Apr 25, 2012Phase 3 study in Inflammatory Bowel DiseasesPharmacosmos · NCT01599702 · 21 enrolled · Denmark
- Jun 26, 20133 phase 3 studiesPharmacosmos · NCT01895231, NCT01895218, NCT01895205
- Apr 28, 2014Phase 3 study in Anemia, Iron-DeficiencyPharmacosmos · NCT02130063 · 511 enrolled · United States
- Jun 21, 2014Phase 3 study in Anemia, Iron-DeficiencyPharmacosmos · NCT02172001 · United States
- Mar 30, 2015Phase 2 study in Restless Legs SyndromePharmacosmos · NCT02484768
- Sep 27, 20162 phase 3 studies in Anemia, Iron-DeficiencyPharmacosmos · NCT02940886, NCT02940860
- Nov 9, 2016Phase 3 study in Anemia, Iron-DeficiencyPharmacosmos · NCT02962648 · 103 enrolled · United States
- Dec 22, 2016Phase 1 study in AnemiaPharmacosmos · NCT03013439 · 24 enrolled · Japan
- Jun 13, 2017Phase 4 study in Iron Deficiency Anemia of PregnancyPharmacosmos · NCT03188445 · 201 enrolled · Denmark
- Jul 6, 20172 phase 3 studies in Anemia, Iron-DeficiencyPharmacosmos · NCT03238911, NCT03237065
- Mar 6, 2018Phase 4 study in IBDPharmacosmos · NCT03466983 · 97 enrolled · Denmark
- Nov 16, 2021Phase 3 study in Iron DeficienciesPharmacosmos · NCT05179226 · 200 planned · United States
- Apr 8, 2025Phase 3 study in Iron DeficienciesPharmacosmos · NCT06929806 · 1,900 planned · United States
- Jul 27, 2026Sichuan Huiyu Pharmaceutical’s first study: phase 1 study in Anemia, Iron-DeficiencyNew to Sichuan Huiyu PharmaceuticalSichuan Huiyu Pharmaceutical · NCT07790562 · 88 planned · China
Ahead
- Apr 30, 2027Primary completion: phase 3 study in Iron DeficienciesPharmacosmos · NCT05179226
- Dec 1, 2027Primary completion: phase 3 study in Iron DeficienciesPharmacosmos · NCT06929806
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 30 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT07790562Anemia, Iron-Deficiency · China | 1 | Recruiting | Sichuan Huiyu Pharmaceutical | Sep 29, 2026 | 88 |
| NCT06929806Iron Deficiencies · United States | 3 | Recruiting | Pharmacosmos | Dec 1, 2027 | 1,900 |
| NCT05179226Iron Deficiencies · United States | 3 | Recruiting | Pharmacosmos | Apr 30, 2027 | 200 |
| NCT03466983IBD · Denmark | 4 | Completed | Pharmacosmos | May 25, 2020 | 97 |
| NCT03238911Anemia, Iron-Deficiency · United States | 3 | Completed | Pharmacosmos | Jun 19, 2018 | 123 |
| NCT03237065Anemia, Iron-Deficiency · United States | 3 | Completed | Pharmacosmos | May 29, 2018 | 122 |
| NCT03188445Iron Deficiency Anemia of Pregnancy · Denmark | 4 | Completed | Pharmacosmos | Jun 26, 2020 | 201 |
| NCT03013439Anemia · Japan | 1 | Completed | Pharmacosmos | Jun 4, 2017 | 24 |
| NCT02962648Anemia, Iron-Deficiency · United States | 3 | Completed | Pharmacosmos | Jun 12, 2018 | 103 |
| NCT02940886Anemia, Iron-Deficiency · United States | 3 | Completed | Pharmacosmos | Mar 28, 2018 | 1,512 |
| NCT02940860Anemia, Iron-Deficiency · United States | 3 | Completed | Pharmacosmos | May 29, 2018 | 1,538 |
| NCT02484768Restless Legs Syndrome | 2 | Withdrawn | Pharmacosmos | Feb 2015 | 0 |
| NCT02172001Anemia, Iron-Deficiency · United States | 3 | Withdrawn | Pharmacosmos | Mar 2015 | 0 |
| NCT02130063Anemia, Iron-Deficiency · United States | 3 | Completed | Pharmacosmos | Aug 2015 | 511 |
| NCT01895231Anemia, Iron-Deficiency · Denmark | 3 | Completed | Pharmacosmos | Dec 2016 | 107 |
| NCT01895218Postpartum Hemorrhage · Denmark | 3 | Completed | Pharmacosmos | Dec 2014 | 200 |
| NCT01895205Postpartum Hemorrhage · Denmark | 3 | Completed | Pharmacosmos | Aug 2015 | 13 |
| NCT01599702Inflammatory Bowel Diseases · Denmark | 3 | Completed | Pharmacosmos | Dec 2014 | 21 |
| NCT01563367Anemia · Denmark | 3 | Completed | Pharmacosmos | Aug 2013 | 74 |
| NCT01469078Renal Insufficiency, Chronic | 1 | Completed | Pharmacosmos | Apr 2012 | 18 |
| NCT01410435Inflammatory Bowel Diseases · Austria, Hungary | 3 | Completed | Pharmacosmos | Aug 2013 | 39 |
| NCT01280240Anemia · United States | 1 | Completed | Pharmacosmos | Sep 2012 | 11 |
| NCT01222884Renal Insufficiency, Chronic · India | 3 | Completed | Pharmacosmos | Oct 2013 | 351 |
| NCT01213992Non-dialysis Dependent Chronic Kidney Disease | 1 | Completed | Pharmacosmos | Oct 2012 | 16 |
| NCT01213680Inflammatory Bowel Diseases | 1 | Completed | Pharmacosmos | Aug 2012 | 16 |
| NCT01145638Neoplasms · India | 3 | Completed | Pharmacosmos | Apr 2014 | 350 |
| NCT01102413Anemia, Iron-Deficiency · Denmark | 3 | Completed | Pharmacosmos | Jun 2014 | 351 |
| NCT01017614Inflammatory Bowel Diseases · Denmark, India, United Kingdom | 3 | Completed | Pharmacosmos | Jul 2012 | 350 |
| NCT00537186Heart Failure · Denmark | 3 | Completed | Pharmacosmos | Jul 2008 | 20 |
| NCT00536666Renal Insufficiency, Chronic · Denmark | 3 | Completed | Pharmacosmos | Aug 2008 | 182 |
How it is read
Names in the registry
- “Iron isomaltoside 1000”, 6 entries
- “Iron isomaltoside/ferric derisomaltose”, 5 entries
- “Monofer”, 5 entries
- “Ferric Derisomaltose”, 2 entries
- “Iron Isomaltoside”, 2 entries
Conditions, from the studies’ own filings
- Anemia, Iron-Deficiency, 12 studies
- Inflammatory Bowel Diseases, 4 studies
- Renal Insufficiency, Chronic, 3 studies
- Iron Deficiencies, 2 studies
- Postpartum Hemorrhage, 2 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.